HXL
Hexima Limited
🇦🇺 ASX
🧬 BIOTECHNOLOGY
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-23.00%
Annual Growth
4 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Hexima Ltd. is a clinical stage, anti-infectives focused biotechnology company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-01. The firm is exploring opportunities for transactions with third parties which could enable the potential value of the Company’s assets, including its intellectual property and other intangible assets, to be realized.
📈 Performance
Price History
-93.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in HXL
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
6 days
💵 Average investment amount
$500
⏰ Last time a customer invested in HXL
133 days
HXL investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in HXL also invest in...
Want more shares? Try these...
Hydrix Ltd. engages in the development, design, and commercialization of technologies in the micro-electronic-mechanical systems (MEMS) sensor industry. The company is headquartered in Mulgrave, Victoria and currently employs 60 full-time employees. The company went IPO on 2001-05-11. The firm is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.
🙌 Performance (5Yr p.a)
-19.09%
📊 Share price
$0.01 AUD
🔨 COMMERCIAL SERVICES & SUPPLIES
HYGG.AX was created on 2014-06-01 by Hyperion. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to achieve long-term returns above the benchmark, and minimise the risk of permanent capital loss
🙌 Performance (5Yr p.a)
32.52%
📊 Share price
$6.93 AUD
🇦🇺 EX AUSTRALIA
🛍️ CONSUMER
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
